Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ABT Relative to the S&P 500

ABT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Abbott Laboratories (NYSE:ABT) seasonal charts above shows that a Buy Date of January 23 and a Sell Date of April 15 has resulted in a geometric average return of 0.92% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 1.27% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

To download ABT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ABT